• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder.使用缓释注射用阿立哌唑成功治疗双相I型障碍的抑郁症状
Case Rep Psychiatry. 2020 Feb 21;2020:2615748. doi: 10.1155/2020/2615748. eCollection 2020.
2
A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.阿立哌唑治疗双相抑郁的临床评价及双相障碍的维持治疗。
J Affect Disord. 2011 Jan;128 Suppl 1:S21-8. doi: 10.1016/S0165-0327(11)70005-2.
3
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.阿立哌唑用于双相 I 型障碍的维持治疗：综述。
Clin Ther. 2010;32 Suppl 1:S32-8. doi: 10.1016/j.clinthera.2010.01.022.
4
Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.现代抗精神病药在双相情感障碍安慰剂对照试验中的疗效：荟萃分析。
Int J Neuropsychopharmacol. 2010 Feb;13(1):5-14. doi: 10.1017/S1461145709990344. Epub 2009 Jul 29.
5
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.阿立哌唑单药治疗非精神病性双相I型抑郁症：两项随机、安慰剂对照研究的结果
J Clin Psychopharmacol. 2008 Feb;28(1):13-20. doi: 10.1097/jcp.0b013e3181618eb4.
6
Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.长效注射抗精神病药（LAIs）用于双相情感和分裂情感障碍的维持治疗：系统评价。
Eur Neuropsychopharmacol. 2019 Apr;29(4):457-470. doi: 10.1016/j.euroneuro.2019.02.003. Epub 2019 Feb 12.
7
Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports.阿立哌唑增效治疗难治性双相抑郁：两例病例报告。
Turk Psikiyatri Derg. 2011 Winter;22(4):269-72.
8
Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.阿立哌唑辅助治疗重度抑郁症：一项针对对抗抑郁药反应欠佳患者的双盲、安慰剂对照研究。
CNS Spectr. 2009 Apr;14(4):197-206. doi: 10.1017/s1092852900020216.
9
The Utility of Low-Dose Aripiprazole for the Treatment of Bipolar II and Bipolar NOS Depression.低剂量阿立哌唑治疗双相II型障碍及未特定的双相障碍抑郁发作的效用
J Clin Psychopharmacol. 2017 Feb;37(1):99-101. doi: 10.1097/JCP.0000000000000636.
10
Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials.阿立哌唑治疗双相情感障碍的疗效、安全性和耐受性：一项更新的系统评价和随机对照试验的荟萃分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):289-301. doi: 10.1016/j.pnpbp.2017.06.023. Epub 2017 Jun 23.

本文引用的文献

1
The Utility of Low-Dose Aripiprazole for the Treatment of Bipolar II and Bipolar NOS Depression.低剂量阿立哌唑治疗双相II型障碍及未特定的双相障碍抑郁发作的效用
J Clin Psychopharmacol. 2017 Feb;37(1):99-101. doi: 10.1097/JCP.0000000000000636.
2
A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.阿立哌唑治疗双相抑郁的临床评价及双相障碍的维持治疗。
J Affect Disord. 2011 Jan;128 Suppl 1:S21-8. doi: 10.1016/S0165-0327(11)70005-2.
3
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.阿立哌唑作为心境稳定剂和西酞普兰治疗双相抑郁的辅助用药：一项随机安慰剂对照的初步研究。
Hum Psychopharmacol. 2010 Mar;25(2):126-32. doi: 10.1002/hup.1096.
4
A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.阿立哌唑单药及辅助治疗急性双相抑郁的前瞻性开放标签研究。
J Affect Disord. 2008 Sep;110(1-2):70-4. doi: 10.1016/j.jad.2008.01.004. Epub 2008 Feb 12.
5
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.阿立哌唑单药治疗非精神病性双相I型抑郁症：两项随机、安慰剂对照研究的结果
J Clin Psychopharmacol. 2008 Feb;28(1):13-20. doi: 10.1097/jcp.0b013e3181618eb4.
6
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.开放标签阿立哌唑治疗急性双相抑郁：一项前瞻性试点试验。
J Affect Disord. 2007 Aug;101(1-3):275-81. doi: 10.1016/j.jad.2006.11.025. Epub 2007 Jan 16.

使用缓释注射用阿立哌唑成功治疗双相I型障碍的抑郁症状

Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder.

作者信息

Kuo Joseph, Lin Shih-Ku

机构信息

Department of Psychiatry, Camillians Saint Mary's Hospital Luodong, Yilan, Taiwan.

Taipei City Hospital and Psychiatric Center, Taipei, Taiwan.

出版信息

Case Rep Psychiatry. 2020 Feb 21;2020:2615748. doi: 10.1155/2020/2615748. eCollection 2020.

DOI:10.1155/2020/2615748
PMID:32148990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7054796/
Abstract

Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dose, a high dropout rate, and a high placebo effect might be the reasons of its ineffectiveness. Here, we report a case of a 39-year-old woman with bipolar depression who was successfully treated with ERI aripiprazole.

摘要

长效注射用阿立哌唑适用于精神分裂症及双相I型障碍的维持单药治疗。阿立哌唑的临床试验未能显示出其在双相抑郁治疗中的疗效。有人认为，相对高的剂量、快速的剂量滴定、高脱落率和高安慰剂效应可能是其无效的原因。在此，我们报告一例39岁双相抑郁女性患者，其接受长效注射用阿立哌唑治疗取得成功。